{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:59:03Z","timestamp":1762865943232},"reference-count":117,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.gyobfe.2012.02.015","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T03:48:34Z","timestamp":1333079314000},"page":"241-254","source":"Crossref","is-referenced-by-count":8,"title":["Traitement des bouff\u00e9es de chaleur apr\u00e8s cancer du sein"],"prefix":"10.1016","volume":"40","author":[{"given":"G.","family":"Boutet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gyobfe.2012.02.015_bib0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/13697137.2011.608596","article-title":"Menopausal hot flushes and night sweats: where are we now?","volume":"14","author":"Archer","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0010","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s11606-008-0655-4","article-title":"Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis","volume":"23","author":"Politi","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0015","first-page":"123","article-title":"Management of menopause-associated vasomotor symptoms: current treatment options, challenges and future directions","volume":"2","author":"Pachman","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2011-0174","article-title":"Hot flashes: a review of pathophysiology and treatment modalities","volume":"16","author":"Morrow","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.critrevonc.2005.04.009","article-title":"Hot flushes in breast cancer patients","volume":"57","author":"Mom","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jpainsymman.2003.10.013","article-title":"The association between nocturnal hot flashes and sleep in breast cancer survivors","volume":"27","author":"Savard","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0029-7844(00)00930-3","article-title":"A prospective population-based study of menopausal symptoms","volume":"96","author":"Dennerstein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ajog.2006.05.056","article-title":"Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment","volume":"196","author":"Rapkin","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0045","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/S0140-6736(07)60959-3","article-title":"Clinical update: new treatments for hot flushes","volume":"369","author":"Stearns","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0050","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/annonc\/mdn353","article-title":"Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer","volume":"19","author":"Hickey","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0093-7754(01)90120-4","article-title":"Menopause and breast cancer: symptoms, late effects, and their management","volume":"28","author":"Ganz","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jpainsymman.2008.04.010","article-title":"The influence of breast cancer treatment on the occurrence of hot flashes","volume":"37","author":"Savard","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/gme.0b013e3181d672f6","article-title":"The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care","volume":"17","author":"Hickey","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/13697130903291058","article-title":"What can be done about hot flushes after treatment for breast cancer?","volume":"13","author":"Kontos","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5years\u2019 adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0080","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13697130500487224","article-title":"Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life","volume":"9","author":"Gupta","year":"2006","journal-title":"Climacteric"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0090","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(02)11774-0","article-title":"Hot flushes","volume":"360","author":"Stearns","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0095","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0015-0282(16)58328-9","article-title":"Core body temperature during menopausal hot flushes","volume":"65","author":"Freedman","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2005-869479","article-title":"Pathophysiology and treatment of menopausal hot flashes","volume":"23","author":"Freedman","year":"2005","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200512020-00009","article-title":"Effects of symptomatic status and the menstrual cycle on hot flash-related thermoregulatory parameters","volume":"12","author":"Freedman","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09513590802632514","article-title":"What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause","volume":"25","author":"Rossmanith","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5122(00)00151-1","article-title":"The role of serotonin in hot flushes","volume":"36","author":"Berendsen","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0120","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1200\/JCO.2002.20.6.1436","article-title":"Cooling off hot flashes","volume":"20","author":"Stearns","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0125","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1592\/phco.29.11.1357","article-title":"Use of antidepressants for management of hot flashes","volume":"29","author":"Carroll","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0135","first-page":"170","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0140","doi-asserted-by":"crossref","first-page":"R535","DOI":"10.1186\/bcr1035","article-title":"Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence","volume":"7","author":"Col","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0145","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1297-9589(03)00189-9","article-title":"Th\u00e9rapeutique hormonale substitutive apr\u00e8s cancer du sein\u00a0: une \u00e9tude de 230\u00a0patientes, avec cas-t\u00e9moins","volume":"31","author":"Gorins","year":"2003","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer \u2013 is it safe?), a randomized comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Menopausal hormone therapy after breast cancer: the Stockholm randomized trial","volume":"97","author":"Von Schoultz","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/bcr1272","article-title":"Menopausal hormone therapy after breast cancer","volume":"7","author":"Colditz","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0170","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2005.04.3745","article-title":"Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms","volume":"24","author":"Sestak","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199408113310602","article-title":"Megestrol acetate for the prevention of hot flashes","volume":"331","author":"Loprinzi","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0180","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1789::AID-CNCR27>3.0.CO;2-#","article-title":"Long-term use of megestrol acetate by cancer survivors for the treatment of hot flashes","volume":"82","author":"Quella","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0185","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.2006.10.6179","article-title":"Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest oncology group study 9626","volume":"26","author":"Goodwin","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0190","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/annonc\/mdf151","article-title":"Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study","volume":"13","author":"Bertelli","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0195","doi-asserted-by":"crossref","unstructured":"SOGC\/GOC joint clinical practice guidelines. Progesterone-only and non-hormonal contraception in the breast cancer survivors: joint review and committee opinion of the Society of Obstetricians and Gynaecologists of Canada and the Society of Gynecologic Oncologists of Canada. Int J Gynecol Obstet 2008;101:309\u201318.","DOI":"10.1016\/j.ijgo.2008.01.006"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0200","unstructured":"NICE Clinical guidelines, No.\u00a080. Early and locally advanced breast cancer. National collaborating center for cancer. Cardiff; 2009; p.\u00a092\u20136."},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0205","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial","volume":"10","author":"Kenemans","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0215","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1200\/JCO.1998.16.7.2377","article-title":"Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors","volume":"16","author":"Loprinzi","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0220","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1188\/02.ONF.33-40","article-title":"Venlafaxine for the control of hot flashes: results of a longitudinal continuation study","volume":"29","author":"Barton","year":"2002","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1634\/theoncologist.12-1-124","article-title":"Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer","volume":"12","author":"Carpenter","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","article-title":"Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial","volume":"105","author":"Evans","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0885-3924(02)00379-2","article-title":"A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer","volume":"23","author":"Weitzner","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1008382706068","article-title":"A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil\u00ae) in controlling hot flashes in breast cancer survivors","volume":"11","author":"Stearns","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0250","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes. A randomized controlled trial","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0255","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1200\/JCO.2005.10.081","article-title":"Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial","volume":"23","author":"Stearns","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0260","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0265","first-page":"47","article-title":"Pilot evaluation of citalopram for the relief of hot flashes","volume":"1","author":"Barton","year":"2003","journal-title":"J Support Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0270","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1089\/jpm.2005.8.924","article-title":"Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine","volume":"8","author":"Loprinzi","year":"2005","journal-title":"J Palliat Med"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0275","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1075-122X.2006.00218.x","article-title":"Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen","volume":"12","author":"Kimmick","year":"2006","journal-title":"Breast J"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0280","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10549-009-0425-y","article-title":"The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer","volume":"118","author":"Wu","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.AOG.0000222383.43913.ed","article-title":"Gabapentin, estrogen, and placebo for treating hot flushes","volume":"108","author":"Reddy","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0290","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420\u00a0women with breast cancer: a randomised double-blind placebo-controlled trial","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0295","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clinthera.2009.02.006","article-title":"Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis","volume":"31","author":"Toulis","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0300","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.breast.2010.11.003","article-title":"Tamoxifen, cytochrome P450\u00a0genes and breast cancer clinical outcomes","volume":"20","author":"Singh","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0305","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/appi.ajp.2008.08040482","article-title":"Drug interactions and pharmacogenomics in the treatment of breast cancer and depression","volume":"165","author":"Henry","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0310","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","article-title":"American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer","volume":"28","author":"Burstein","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0315","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2010.08.005","article-title":"Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions","volume":"67","author":"Desmarais","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0320","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1200\/JCO.2009.23.8931","article-title":"Coprescription of tamoxifen and medications that inhibit CYP2D6","volume":"28","author":"Sideras","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0325","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1158\/1078-0432.CCR-08-0619","article-title":"Cytochrome P450 2D6\u00a0and homeobox 13\/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance","volume":"14","author":"Goetz","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0330","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.2009.1420","article-title":"Association between CYP2D6\u00a0polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen","volume":"302","author":"Schroth","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0335","doi-asserted-by":"crossref","first-page":"c693","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0340","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10549-010-1162-y","article-title":"Concurrent use of tamoxifen with CYP2D6\u00a0inhibitors and the risk of breast cancer recurrence","volume":"126","author":"Azoulay","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0345","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jnci\/djr010","article-title":"CYP2D6\u00a0inhibition and breast cancer recurrence in a population-based study in Denmark","volume":"103","author":"Lash","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0350","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10549-010-1008-7","article-title":"Potent CYP2D6\u00a0inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen","volume":"125","author":"Siegelmann-Danieli","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0355","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2165\/11595660-000000000-00000","article-title":"Serotonin reuptake inhibitors and hyperprolactinaemia. A case\/non-case study in the french pharmacovigilance database","volume":"34","author":"Trenque","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0360","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.2006.07.6356","article-title":"A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer","volume":"25","author":"Tworoger","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0365","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/EJE-11-0076","article-title":"Cancer risk in hyperprolactinemia patients: a population-based cohort study","volume":"165","author":"Berinder","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0370","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0895-4356(02)00568-1","article-title":"Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer","volume":"56","author":"Lawlor","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0375","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0015-0282(00)00563-X","article-title":"Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women","volume":"74","author":"Freedman","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0380","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","article-title":"Transdermal clonidine for ameliorating tamoxifene-induced hot flashes","volume":"12","author":"Goldberg","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0385","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","article-title":"Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a university of Rochester cancer center community clinical oncology program study","volume":"132","author":"Pandya","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0390","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1998.16.2.495","article-title":"Prospective evaluation of vitamine E for hot flashes in breast cancer survivors","volume":"16","author":"Barton","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4065\/83.1.23","article-title":"Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis","volume":"83","author":"Bardia","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0400","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1470-2045(00)00289-8","article-title":"Management of hot flashes in breast-cancer survivors","volume":"2","author":"Loprinzi","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0405","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1200\/JCO.2011.37.5865","article-title":"Nonestrogenic management of hot flashes","volume":"29","author":"Loprinzi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0410","first-page":"2385","article-title":"Abuf\u00e8ne 400mg et bouff\u00e9es de chaleur. \u00c9tude en double aveugle versus placebo","volume":"5","author":"Roueche","year":"1991","journal-title":"Rev Prat Med Gen"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0415","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1200\/JCO.2008.19.6253","article-title":"Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis","volume":"27","author":"Loprinzi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0420","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jpainsymman.2003.07.007","article-title":"Hot flashes refractory to HRT and SSRI therapy but responsive to gabapentin therapy","volume":"27","author":"Guttuso","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0425","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2006.07.5390","article-title":"Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5","volume":"25","author":"Loprinzi","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0430","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1200\/JCO.2010.29.9230","article-title":"Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors","volume":"28","author":"Bordeleau","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0435","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdl478","article-title":"Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients \u2013 a double-blind, randomized study","volume":"18","author":"Loibl","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0440","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-008-0138-7","article-title":"Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study","volume":"115","author":"Buijs","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0445","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1200\/JCO.2010.33.1298","article-title":"Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-bind, placebo-controlled trial","volume":"29","author":"Boekhout","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0450","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.2005.04.7324","article-title":"Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North central cancer treatment group trial N99C7","volume":"24","author":"Loprinzi","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0455","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.maturitas.2009.12.019","article-title":"Controversies concerning the use of phytoestrogens in menopause management: bioavailability and metabolism","volume":"65","author":"de Cremoux","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0460","first-page":"CD001395","article-title":"Phytoestrogens for vasomotor menopausal symptoms","volume":"4","author":"Lethaby","year":"2007","journal-title":"Cochrane Database Sys Rev"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0465","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1200\/JCO.2000.18.5.1068","article-title":"Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer suvivors: a north central cancer treatment group trial","volume":"18","author":"Quella","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0470","first-page":"401","article-title":"Les phytoestrogens dans les contre-indications du THS, le probl\u00e8me du cancer du sein","volume":"28","author":"This","year":"2000","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0475","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinthera.2007.02.006","article-title":"Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review","volume":"29","author":"Bordeleau","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0480","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.maturitas.2011.07.001","article-title":"A critical view of the effects of phytoestrogens on hot flashes and breast cancer risk","volume":"70","author":"This","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/acm.2005.11.13","article-title":"A pilot, randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast-cancer survivors","volume":"11","author":"Thompson","year":"2005","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0490","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/acm.2005.11.21","article-title":"Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial","volume":"11","author":"Jacobs","year":"2005","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0495","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-008-0230-z","article-title":"Acupuncture for treating hot flashes in breast cancer patients: a systematic review","volume":"115","author":"Lee","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0500","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/gme.0b013e3181a48abd","article-title":"Acupuncture for vasomotor menopausal symptoms: a systematic review","volume":"16","author":"Cho","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0505","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2009.23.5150","article-title":"Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial","volume":"28","author":"Walker","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0510","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1200\/JCO.2007.12.0774","article-title":"Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients","volume":"25","author":"Deng","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0515","unstructured":"Liljegren A, Gunnarsson P, Landgren BM, Rob\u00e9us N, Johansson H, Rotstein S. Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial. Breast Cancer Res Treat 2010, doi:10.1007\/s 10549-010-1283-3."},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0520","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/bmj.297.6657.1169","article-title":"Relaxation and imagery in the treatment of breast cancer","volume":"297","author":"Bridge","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0525","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/pon.1096","article-title":"Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors","volume":"16","author":"Elkins","year":"2007","journal-title":"Psychooncology"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0530","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1200\/JCO.2008.16.6389","article-title":"Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors","volume":"26","author":"Elkins","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0535","first-page":"CD004923","article-title":"Non-hormonal interventions for hot flushes in women with a history of breast cancer","volume":"9","author":"Rada","year":"2010","journal-title":"Cochrane Database Sys Rev"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0540","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.GME.0000108177.85442.71","article-title":"Treatment of menopause-associated vasomotor symptoms: position statement of the North American menopause society","volume":"11","author":"North American Menopause Society","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0545","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1470-2045(08)70131-1","article-title":"Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study","volume":"9","author":"Lipov","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0550","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1470-2045(08)70218-3","article-title":"Updated findings on the effects of stellate-ganglion block on hot flushes and night awakenings","volume":"9","author":"Lipov","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0555","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00520-010-0907-9","article-title":"Pilot evaluation of a stellate ganglion block for the treatment of hot flushes","volume":"19","author":"Pachman","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0560","doi-asserted-by":"crossref","unstructured":"Haest K, Kumar A, Van Calster B, Leunen K, Smeets A, Amant F, et al. Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24weeks of follow-up. Ann Oncol 2011, doi:10 1093\/annonc\/mdr478.","DOI":"10.1093\/annonc\/mdr478"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0565","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1001\/jama.293.20.2479","article-title":"Physical activity and survival after breast cancer diagnosis","volume":"293","author":"Holmes","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0570","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1055-9965.EPI-07-0771","article-title":"Physical activity after diagnosis of invasive breast cancer","volume":"17","author":"Holick","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0575","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1634\/theoncologist.11-6-641","article-title":"Symptoms and treatment in cancer therapy-induced early menopause","volume":"11","author":"Boekhout","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0580","first-page":"339","article-title":"Traitement des bouff\u00e9es de chaleur associ\u00e9es au cancer du sein","volume":"91","author":"Debourdeau","year":"2004","journal-title":"Bull Cancer"},{"key":"10.1016\/j.gyobfe.2012.02.015_bib0585","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1470-2045(05)70316-8","article-title":"Management of menopausal symptoms in patients with breast cancer: an evidence-based approach","volume":"6","author":"Hickey","year":"2005","journal-title":"Lancet Oncol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958912000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958912000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T22:53:47Z","timestamp":1641682427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958912000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1297958912000501"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2012.02.015","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}